Bio-Rad Laboratories Inc (BIO) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $275.02
• Market Cap: $7.28B
• P/E Ratio: 9.65
• EPS: $27.94
• 52-Week High: $343.12
• 52-Week Low: $211.43

Market Sentiment

Bio-Rad Laboratories Inc currently has a Neutral sentiment score of 0.09.

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. is a premier global provider of innovative solutions in life sciences research and clinical diagnostics, delivering a comprehensive portfolio of products and technologies designed to advance scientific discovery and enhance patient care. The company specializes in tools for genomic research, proteomics, and diagnostic testing, catering to the diverse needs of researchers and healthcare professionals. With a steadfast commitment to quality and reliability, Bio-Rad's ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Bio-Rad Laboratories Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BIO pay dividends?

Bio-Rad Laboratories Inc (BIO) does not currently pay a regular dividend.

What is BIO's P/E ratio?

Bio-Rad Laboratories Inc has a price-to-earnings (P/E) ratio of 9.65.

What is BIO's market cap?

Bio-Rad Laboratories Inc (BIO) has a market capitalization of $7.28B with a current stock price of $275.02.